These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9789468)

  • 1. [Appetite depressants and pulmonary hypertension].
    Hellermann J; Salomon F
    Ther Umsch; 1998 Sep; 55(9):548-50. PubMed ID: 9789468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Appetite suppressants and heart valve disorders].
    Adams C; Cohen A
    Arch Mal Coeur Vaiss; 1999 Sep; 92(9):1213-9. PubMed ID: 10533670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appetite suppressants and pulmonary hypertension: a long-term risk.
    Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131516
    [No Abstract]   [Full Text] [Related]  

  • 4. Temporal trends and drug exposures in pulmonary hypertension: an American experience.
    Walker AM; Langleben D; Korelitz JJ; Rich S; Rubin LJ; Strom BL; Gonin R; Keast S; Badesch D; Barst RJ; Bourge RC; Channick R; Frost A; Gaine S; McGoon M; McLaughlin V; Murali S; Oudiz RJ; Robbins IM; Tapson V; Abenhaim L; Constantine G
    Am Heart J; 2006 Sep; 152(3):521-6. PubMed ID: 16923424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anorexigen-related cardiopulmonary toxicity.
    Gross SB; Lepor NE
    Rev Cardiovasc Med; 2000; 1(2):80-9, 102. PubMed ID: 12457145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine.
    Mark EJ; Patalas ED; Chang HT; Evans RJ; Kessler SC
    N Engl J Med; 1997 Aug; 337(9):602-6. PubMed ID: 9271482
    [No Abstract]   [Full Text] [Related]  

  • 7. Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study.
    Palmieri V; Arnett DK; Roman MJ; Liu JE; Bella JN; Oberman A; Kitzman DW; Hopkins PN; Morgan D; de Simone G; Devereux RB
    Am J Med; 2002 Jun; 112(9):710-5. PubMed ID: 12079711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appetite-suppressant drugs and valvular heart disease.
    Shapiro S
    N Engl J Med; 1999 Feb; 340(6):477-8; author reply 478-80. PubMed ID: 9988622
    [No Abstract]   [Full Text] [Related]  

  • 9. [Appetite depressant drugs and the risk of primary pulmonary hypertension].
    Olschewski H
    Pneumologie; 1997 Jun; 51(6):575-6. PubMed ID: 9333790
    [No Abstract]   [Full Text] [Related]  

  • 10. A close look at fenfluramine and dexfenfluramine.
    Vivero LE; Anderson PO; Clark RF
    J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anorexigen-induced cardiac valvulopathy and female gender.
    Naqvi TZ; Gross SB
    Curr Womens Health Rep; 2003 Apr; 3(2):116-25. PubMed ID: 12628081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus and pulmonary hypertension during pregnancy: report of a case fatality.
    Ray J; Sermer M
    Can J Cardiol; 1996 Aug; 12(8):753-6. PubMed ID: 8794779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A big fat settlement. But lawyers for diet-drug users suggest that $3.75 billion is not nearly enough.
    Schultz S
    US News World Rep; 1999 Oct; 127(15):74. PubMed ID: 10623292
    [No Abstract]   [Full Text] [Related]  

  • 14. Aminorex and pulmonary hypertension. A review.
    Gurtner HP
    Cor Vasa; 1985; 27(2-3):160-71. PubMed ID: 3928246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appetite suppressants and cardiac valvulopathy. Current clinical perspectives.
    Gross SB
    Adv Nurse Pract; 1999 Oct; 7(10):36-40. PubMed ID: 10808770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine.
    Tomita T; Zhao Q
    Chest; 2002 Feb; 121(2):649-52. PubMed ID: 11834685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Too late, again?
    Jones NL
    Can Respir J; 2001; 8(3):127-8. PubMed ID: 11420587
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population.
    Schoonjans AS; Marchau F; Paelinck BP; Lagae L; Gammaitoni A; Pringsheim M; Keane MG; Ceulemans B
    Curr Med Res Opin; 2017 Oct; 33(10):1773-1781. PubMed ID: 28704161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appetite-suppressant drugs and valvular heart disease.
    Williamson DF; Yanovski SZ
    N Engl J Med; 1999 Feb; 340(6):476; author reply 478-80. PubMed ID: 9988618
    [No Abstract]   [Full Text] [Related]  

  • 20. [Severe pulmonary hypertension complicating a long treatment with dexfenfluramine].
    Ferrari E; Drai E; Jourdan J; Sanchez B; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1994 Feb; 87(2):285-6. PubMed ID: 7802538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.